Market Access and Reimbursement Risk Assessment.
Built by former payers, HTA reviewers, and Industry Experts.
Summary Blackstone, a leading private equity firm, has announced the closure of a new $6.3 billion fund dedicated to investing in the life sciences sector. The fund, named Blackstone Life
Novartis acquires Excellergy, a startup focused on developing allergy treatments, in hopes of finding a successor to their current drug Xolair. The deal, worth up to $280 million, includes an
Summary Merck has announced its plans to acquire Terns Pharmaceuticals for $6.7 billion, in a move to bolster its oncology portfolio. The deal includes Terns’ lead drug candidate, TRN-823, which
Novartis pays $2B to land a startup’s breast cancer drug Summary Novartis has announced a $2 billion deal to acquire Synnovation, a startup developing a PI3Kα inhibitor for the treatment
Summary RBC Capital Markets has identified three biotech companies, Revolution, Xenon, and Arrowhead, as potential takeover targets in the current M&A landscape. These companies have strong drug pipelines and promising
What 46 Drugs Approved in 2025 Reveal About Payer Evidence Expectations FDA approval is often treated as the defining milestone for a new medicine. But approval alone does not guarantee
Gilead to Acquire Arcellx in $7.8B Deal for Multiple Myeloma Cell Therapy Summary Gilead Sciences has announced its acquisition of Arcellx, its longtime development partner, for $7.8 billion. This deal
Lilly Acquires Orna Therapeutics to Advance Cell Therapy for Autoimmune Diseases Summary Lilly has announced its acquisition of Orna Therapeutics, a biotechnology startup specializing in circular RNA medicines. The deal,
Summary The Trump administration has launched an online portal called TrumpRx that offers around 40 drugs from select manufacturers at discounted prices. However, the impact of this service may be
Novo Combination Obesity Shot Meets Goal in Diabetes Trial Summary Novo Nordisk announced positive results from a Phase 3 trial for their experimental combination shot, CagriSema, in people with diabetes